The biopharmaceutical industry is an important strategic industry of the "14+7" industrial cluster in Nanshan District. In recent years, with the development and maturity of peptide synthesis technology, peptide drugs have become one of the hot spots in drug research and development.

On July 11, Shenzhen Lihe Biotechnology Co., Ltd. and Shenzhen Peptide Sheng Biotechnology Co., Ltd. signed an agreement and reached a strategic cooperation relationship. The two parties will integrate resources to jointly promote the construction of the world's first entity peptide library application development that combines peptide structural d

In the midsummer, the Bay Area gathers together. From June 27th to 29th, the "Gathering in the Mountains and Seas to Write the GLP-1 Heroes" private meeting was successfully held in Shenzhen, Guangdong! More than 50 outstanding experts, entrepreneurs and investors in the field of GLP-1/peptide drugs gathered in Shenzhen Bay to discuss the developme

In order to further promote the exchange and cooperation between peptide ingredient innovation and the cosmetics industry, on August 31, Shenzhen Peptide Shengmei Biotechnology Co., Ltd. (hereinafter referred to as "Peptide Shengmei") held the "Peptide Beauty China·Beauty Industry Peptide Innovation Summit Forum" at Lanzhou Peptide Valley Research